ORIGINAL RESEARCH article
Front. Cell. Infect. Microbiol.
Sec. Clinical Infectious Diseases
Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1547998
This article is part of the Research TopicTargeted Next-Generation Sequencing for Pathogen and Antimicrobial Resistance (AMR) Identification and ProfilingView all 13 articles
Predicting ventilator-associated lower respiratory tract infection outcomes using sequencing-based early microbiological response: A proof-of-concept prospective study
Provisionally accepted- 1Department of Respiratory and Critical Care Medicine, First Affiliated Hospital, Nanjing Medical University, Nanjing, China
- 2Jiangsu Health Vocational College, Nanjing, Jiangsu Province, China
- 3Clinical Medicine Research Institution, First Affiliated Hospital, Nanjing Medical University, Nanjing, China
- 4Geneplus Beijing Institute, Huilongguan Town, Beijing, China
- 5Department of Laboratory Medicine, First Affiliated Hospital, Nanjing Medical University, Nanjing, China
- 6Vanderbilt University Medical Center, Nashville, Tennessee, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objectives: Ventilator-associated lower respiratory tract infections (VA-LRTIs) cause significant mortality. This study was assigned to explore the association between early microbiological responses defined by quantitative targeted amplicon-based next-generation sequencing (QtNGS) and clinical outcomes in patients with Acinetobacter baumannii-dominant VA-LRTI.A prospective observational study including 34 participants was conducted to assess the probability of predicting clinical outcomes using sequencing-based early microbiological response. Bronchoalveolar lavage fluids (BALFs) were collected at admission and 3 days post-treatment from these patients for QtNGS to determine the relative quantification ratio (RQR) of A. baumannii. Patients were categorized into survival (n=26) and non-survival (n=8) groups. The RQR was calculated as the quantification of A. baumannii determined by QtNGS after treatment to pretreatment. RQR significantly increased on day 4 in the non-survival group (median 5.285), and decreased in the survival group (median 0.1864).Receiver's operation characteristic curves revealed that an RQR ≥1.41 was predictive of poor outcomes, with an area under the curve of 0.9471 (0.8759-1). The accuracy of the RQR determined by QtNGS was further evaluated by retesting the same specimen using digital droplet PCR, and the linear correlation was confirmed in the RQR calculated by two methods. The 23 patients with RQR<1.41 all survived for 28 days, whereas the survival rate for the 11 patients with RQR ≥1.41 was 27.27%. RQR was significantly and positively correlated with the length of ICU stay in survivors.The RQR of A. baumannii detected by QtNGS correlates with the prognosis of VA-LRTI patients.
Keywords: NGS, VA-LRTI, VAP, A. baumannii, Microbiological response
Received: 19 Dec 2024; Accepted: 21 Apr 2025.
Copyright: © 2025 Zhou, Qian, Jing, Liu, Wang, Wang, Ding, Gu, Xia, Tao and Sun. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Lili Tao, Vanderbilt University Medical Center, Nashville, 37232, Tennessee, United States
Wenkui Sun, Department of Respiratory and Critical Care Medicine, First Affiliated Hospital, Nanjing Medical University, Nanjing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.